L eukocytosis has been associated with higher rates of ischemic vascular disease in numerous prospective and cross-sectional studies. [1] [2] [3] The monocyte count, in particular, independently predicts risk for coronary artery disease after adjustment for conventional risk factors. 4 Monocytosis and neutrophilia have also been observed in animal models of atherosclerosis including pigs and rabbits and seem to contribute to atherogenesis. 5, 6 Hypercholesterolemia-induced monocytosis has been documented in ApoE −/− mice in association with a marked increase in the Ly-6C hi monocyte subset, a subpopulation that more readily infiltrates lesions. 7, 8 (WTD), where monocytosis and neutrophilia were associated with HSPC expansion. 16 Chimeric BM transplantation experiments revealed that the ApoE −/− HSPCs outcompeted wild-type (WT) HSPCs in giving rise to monocytes and neutrophils when transplanted into Ldlr −/− mice and that the Abca1 
Abcg1
−/− HSPCs compared with WT HSPCs. 16 In both studies, the cell intrinsic proliferative advantage was associated with increased cell surface levels of the common β subunit of the granulocyte M-CSF (GM-CSF)/interleukin-3 (IL-3) receptor (CBS). Another study, using ApoE −/− mice as a model, identified increased numbers of GM-CSF producing cells in the spleen and underscored the importance of extramedullary expansion of HSPCs and myeloid progenitor cells in the spleen as drivers of monocytosis and atherogenesis. 17 The same group later described innate response activator (IRA) B cells that protect the hosts from polymicrobial sepsis through lipopolysaccharide-induced production of GM-CSF specifically in the spleen. 18 Interestingly, these IRA B cells develop from peritoneal B1a cells in a CBS-dependent manner, suggesting a feed-forward loop in GM-CSF production from IRA B cells under certain stress conditions. The CBS (aka CD131) is the β subunit shared by the receptors of IL-3, GM-CSF, and IL-5. In humans, CD131 is encoded by the gene Csf2rb. 19 In mice, Csf2rb1 encodes IL3-βc, the ortholog of CD131, whereas Csf2rb2 encodes IL-3 receptor class II β chain, a second protein that is homologous to CD131 but can only form a functional receptor with the IL-3α subunit. 20 Because of their partial functional redundancy and the fact that a Csf2rb1
Csf2rb2
−/− mouse will be used in this study, CBS will be used to denote the protein product of Csf2rb1 and Csf2rb2 collectively, and Cbs −/− will denote Csf2rb1
. The CBS plays a central role in hematopoiesis, reflecting the function of GM-CSF and IL-3 in myeloid lineage development. 21, 22 IL-3 promotes HSPC survival and proliferation, and GM-CSF determines myeloid lineage specification and mediates the development of monocyte and dendritic cells (DCs), 23, 24 2 cell types that are intimately involved in atherosclerosis.
The hypothesis underlying this study was that increased expression of the CBS in HSPCs and possibly IRA B cells or their progenitors would promote HSPC and IRA B cell expansion, contributing to monocytosis and atherogenesis in ApoE −/− mice.
Materials and Methods
Materials and Methods are available in the online-only Supplement. Cbs −/− BM into Ldlr −/− mice, which did not change plasma cholesterol levels. At 5 weeks after transplantation, BM reconstitution was >90% (results not shown). We observed a major effect of diet-induced hypercholesterolemia in the Ldlr −/− background on blood monocyte and neutrophil counts as reported. 16 
Results

CBS
ApoE
−/−
Cbs
−/− BM-transplanted Ldlr −/− mice had significantly fewer monocytes than ApoE −/− BM-transplanted Ldlr −/− mice after 5 weeks of WTD feeding, and the difference was even more marked after 8 weeks of WTD feeding ( Figure 1A ). CBS deficiency also reduced neutrophil counts after WTD feeding ( Figure 1B ). The changes in monocytes and neutrophil levels were observed in the absence of any significant difference in the cholesterol levels ( Figure 1C ). We also studied the effect of CBS deficiency on monocyte levels in the presence of apolipoprotein E in the BM. When we transplanted Ldlr −/− mice with WT or Cbs −/− BM and fed them the WTD, no effect on blood monocytes was found ( Figure I in the online-only Data Supplement). This was likely because of increased CBS on ApoE −/− but not WT HSPCs, as reported. 16 Therefore, for subsequent studies, we used BM donors on the ApoE −/− background.
CBS Deficiency Decreased HSPC Expansion in BM and Spleen in ApoE −/− BM-Transplanted Mice
We compared the HSPC levels and their proliferative activity in the BM and the spleen after 9 weeks of WTD feeding ( Figure 2 ; Figure Figure II in the online-only Data Supplement). ApoE −/− mice are known to develop splenomegaly on WTD feeding, 16 and this was also decreased in the ApoE Cbs −/− group, we investigated the underlying mechanisms. In ApoE −/− mice-fed WTD, increased numbers of cells that produce GM-CSF and IL-3 accompanied the increase in monocyte production in the spleen. 17 It has also been reported that peritoneal B1a cells develop into IRA B cells, specifically in the spleen where they produce GM-CSF and IL-3 to protect the host against polymicrobial sepsis. 18 Thus, we examined the possibility that IRA B cells are involved in the enhanced GM-CSF/IL-3 production in the spleen of WTD-fed ApoE 
CBS Plays a Central Role in IRA B Cell Expansion in ApoE −/− Mice
Previous studies demonstrated that B1a cells failed to give rise to IRA B cells in the presence of an antibody against CBS, 18 suggesting that CBS is required for the development of IRA B cells. Our laboratory has reported previously that ApoE −/− mice had increased cell surface level of CBS in HSPCs because of defective cholesterol efflux and lipid raft formation. 16 These observations led us to hypothesize that the enhanced IRA B cell formation in spleen could be because of elevated CBS expression in B1a and IRA B cells. Indeed, ApoE −/− mice have increased CBS surface levels on both IRA B cells ( Figure 3C ; Figure Figure 4B and 4D) while the percentages of macrophages per lesion size were similar in both groups (results not shown). Consistent with these findings, the lesions in these 2 groups were largely cellular with little necrotic core formation ( Figure 4A ). These findings support our hypothesis that reduced monocyte counts arising through CBS deficiency in ApoE −/− hematopoietic tissue leads to decreased macrophage accumulation in early atherogenesis. After 9 weeks of WTD feeding, CBS deficiency did not reduce the overall atherosclerotic plaque size comparing ApoE Figure 5D and 5E), suggesting that the potential atheroprotective effect of reduced monocyte and macrophage content of lesions might be counteracted by increased necrotic core formation.
In an effort to understand the mechanisms that might explain the lack of reduction of overall size of advanced lesions, we considered several potential hypotheses. First, because the CBS transduces signals mediated by IL-5 and IL-5 has been implicated in the production of potentially atheroprotective natural antibodies, such as the IgM E06/T15, 25 we measured titers of these antibodies in plasma. The titers of antibodies were not reduced in ApoE 
BM-transplanted Ldlr
−/− mice. GM-CSF is known to play a role in the development of DCs that activate regulatory T cells (Tregs), 26, 27 an immunosuppressive T-cell population that has been reported to attenuate atherosclerosis, likely through suppressing both T-cell-and macrophage-mediated inflammation and lesional MCP-1 expression.
28,29 Therefore, we quantified the level of DCs and Tregs and found slightly decreased numbers of both cell types in spleens of ApoE Cbs −/− BM and fed the Western-type diet for 9 weeks. Hearts were isolated and fixed, and paraffin sections of the aortic root were made. A, Sections were stained with hematoxylin and eosin (H&E), and atherosclerotic lesion area was quantified by morphometric analysis (n=24-25). B, Sections were stained for F4/80, and macrophage-positive area was quantified (n=14-16). C, Sections were stained for Masson Trichrome, and collagen-positive area was quantified (n=8). D, Necrotic core area was quantified on H&E stained sections (n=13-16 (Figure 6A ), and this was associated with a decrease in Pparγ expression ( Figure 6B ), a ≈70% increase in the proapoptotic protein caspase 3 ( Figure 6C and 6E) , and a 3-fold increase in the number of apoptotic cells as determined by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining ( Figure 6D ; Figure IX in the online-only Data Supplement).
Discussion
Previous studies have shown increased levels of the CBS associated with increased myeloid proliferative responses to GM-CSF and IL-3 in BM HSPCs of hypercholesterolemic mice with defective cellular cholesterol efflux pathways and also in the widely used ApoE −/− mouse model. 15, 16 However, the in vivo significance of increased cell surface CBS levels and signaling in monocytosis and atherosclerosis remained uncertain. Our study provides direct evidence that the CBS . Common β subunit of the granulocyte macrophage colony-stimulating factor (GM-CSF)/ interleukin-3 (IL-3) receptor (CBS) deficiency in bone marrow (BM) ApoE deficiency decreases Abcg1 and Pparγ mRNA expression and increases apoptosis in atherosclerotic lesions. Ldlr −/− mice transplanted with BM of specified genotype were fed Western-type diet for 9 weeks, and frozen sections of aortic roots were prepared. RNA was extracted from laser-captured macrophages from atherosclerotic lesions, and Abcg1 (A) and Pparγ (B) mRNA were measured. C, Sections were stained for the proapoptotic protein caspase 3. D, TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining was performed to identify apoptotic cells. E, Representative pictures of caspase 3 staining. Arrows indicate caspase 3 positive cells (n=9-10). *P<0.05, **P<0.01, as determined by t test. F, Under hypercholesterolemic conditions in hematopoietic apolipoprotein E (apoE) deficiency, increased CBS expression in hematopoietic stem and multipotential progenitor cells (HSPCs) increases the production of myeloid cells. In spleen, CBS increases GM-CSF and IL-3 production by facilitating innate response activator (IRA) B cell development and potentially enhances extramedullary myeloid proliferation and monocytosis.
plays a key role in mediating the monocytosis that develops in hypercholesterolemic ApoE −/− mice. In the BM and spleen, the CBS is required for the hypercholesterolemia-driven HSPC and myeloid expansion; in the spleen, the CBS also likely increases GM-CSF and IL-3 production by facilitating IRA B cell formation. IRA B cells account for ≈70% of the GM-CSF production in the spleen, 34 suggesting that IRA B cells could contribute to enhanced myeloid proliferation and monocytosis in ApoE −/− BM-transplanted Ldlr −/− mice ( Figure 6F ). Moreover, CBS deficiency ameliorated plaque burden, including macrophage content during early atherogenesis. Unexpectedly, in more advanced atherosclerotic lesions, CBS deficiency decreased macrophage content but increased necrotic core areas, resulting in no net change of plaque area. This suggests that GM-CSF signaling via the CBS promotes atherosclerotic plaque stabilization in more advanced lesions.
BM-derived HSPCs are known to traffic through blood to extramedullary sites including the spleen where they proliferate and give rise to resident myeloid cells during both steady state conditions and inflammation. [35] [36] [37] This phenomenon also occurs in animal models of atherosclerosis.
15,17
Abca1
−/− Abcg1 −/− mice showed infiltration of HSPCs in the lung, spleen, and liver as a result of increased signaling through the IL-23/IL-17/G-CSF axis, 38 and ApoE −/− mice developed splenomegaly with WTD feeding, reflecting enhanced HSPC proliferation and myelopoiesis in the spleen. 17 Recent studies have highlighted the significance of the spleen as a site of extramedullary myeloproliferation and a source of monocytes in accelerated atherosclerosis after myocardial infarction. 37, 39 Our study shows a critical role of the CBS in facilitating extramedullary monocyte production through the development and expansion of IRA B cells, which likely contribute to myeloid proliferation in the spleen by producing GM-CSF and IL-3. Moreover, a decrease in IRA B cells was associated with reduced monocytosis and lesional macrophage burden, suggesting that these cells may contribute to atherogenesis in the ApoE −/− mouse model. Recently, Hilgendorf et al 34 also showed an increase in splenic IRA B cells in mouse atherosclerosis models. Based on an elegant chimeric BM transplantation approach that resulted in a specific depletion of GM-CSF-producing B cells, these authors suggested that GM-CSF-producing IRA B cells accelerate atherogenesis by increasing IL12p40-producing CD11b + DCs in the spleen, leading to activation of CD4 + T cells and production of interferon γ, contributing to macrophage inflammation in lesions. Because we observed a decrease in splenic DCs in ApoE 40 Evidence has also emerged to paint a more complex picture of the pathogenesis with differing characteristics between early and advanced atherosclerotic lesions. 41, 42 Strikingly, in our model, the reduction of monocyte levels had differential effects on early lesions and advanced lesions. In early lesions, the reduction of monocytes resulted in decreased macrophage content and decreased lesion size, consistent with the largely cellular nature of early lesions. Our findings are consistent with several earlier studies involving GM-CSF injection or deficiency in atherogenesis. With one exception, 43 most of these studies have shown a proatherogenic role of GM-CSF, [44] [45] [46] thought to be related to proliferation of CD11c + dendritic-like cells in lesions. 44, 45 Many cells that stain for CD11c also stain for macrophage markers, 47 consistent with our findings of decreased lesional macrophages.
In advanced atherosclerotic lesions, CBS deficiency did not decrease lesion size, despite a sustained reduction of blood monocyte counts. This was explained by increased necrotic core formation attributable at least in part to the lack of ABCG1 expression in the lesions. Prior studies have shown that GM-CSF induces macrophage Abcg1 expression mediated by PPARγ. 48 It is known that ABCG1 is critical in sustaining macrophage survival likely by promoting cholesterol and oxysterol efflux, and lack of ABCG1 results in elevated cholesterol and oxysterol levels and enhanced apoptosis. 49 Studies have established that macrophage death may reduce the volume of early atherosclerotic plaques. However, advanced lesions are characterized by defective efferocytosis in which debris from the apoptotic macrophages is not adequately removed, aggravating the inflammatory process in lesions. 50 A recent study found that local macrophage proliferation, rather than monocyte recruitment, plays a major role in maintaining the macrophage content of established atherosclerotic lesions. 51 However, a role for GM-CSF as a proliferative stimulus was specifically excluded in that report, indicating that such a mechanism was not likely involved in our study.
In summary, our study highlights the important role of increased levels of the CBS in mediating cholesterol-driven HSPC expansion in the BM, as well as extramedullary myeloid expansion via IRA B cells in the spleen. These processes contribute to monocytosis and plaque macrophage burden. However, the CBS also seems to play a role in cell survival, at least in part through effects on ABCG1 expression, and thus decreases necrotic core formation and increases collagen content in advanced atherosclerotic lesions. These observations may have significant implications for the development of new anti-inflammatory therapies for autoimmune diseases such as rheumatoid arthritis or multiple sclerosis based on interruption of GM-CSF signaling.
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